about
Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistryIGF-IR Targeted Therapy: Past, Present and FutureDeciding site of biopsy at metastatic relapse.Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicineCD176 single-chain variable antibody fragment inhibits the adhesion of cancer cells to endothelial cells and hepatocytes.Molecular functional imaging in personalized clinical oncology: The road less traveled.In vivo imaging with antibodies and engineered fragments.Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors.Superparamagnetic Gold Nanoparticles Synthesized on Protein Particle Scaffolds for Cancer Theragnosis.On chip analysis of CNS lymphoma in cerebrospinal fluid.Micro-flow photosynthesis of new dienophiles for inverse-electron-demand Diels-Alder reactions. Potential applications for pretargeted in vivo PET imagingDevelopment of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials.Near-Infrared Plasmonic Assemblies of Gold Nanoparticles with Multimodal Function for Targeted Cancer Theragnosis.Antibody Selection on FFPE Tissue Slides.Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers.[Simultaneous whole-body PET-MRI in pediatric oncology : More than just reducing radiation?].
P2860
Q27026010-A3FE3439-17B0-4D79-B2FB-03A5CAC6911DQ28082127-792310CC-2812-4897-B3E1-CF0FF7E652CCQ34389394-87C51ED4-420F-4012-9BDA-5471B0D6A321Q34698624-26B1D796-A883-4F9E-B86D-06CCDDC235F2Q35993085-870D7FD9-E2B1-475D-B213-50D3929798E0Q36696339-C2BC265A-BB49-4163-A897-C58683793219Q38454458-5F4A8695-6255-4E9B-BA47-A26F03667BD4Q39139224-87229000-4424-4835-9209-CA924101496EQ40109469-C632586E-46DA-4313-A0C4-29829CE35070Q40939528-3CE516E8-55B3-4589-887C-F7E77E6B1DC4Q41773129-3C0CA9EF-01A2-4D05-9AC4-858E8A9F92A9Q46597771-56FB6C20-7B19-4C79-9668-350A9152A212Q47122204-6AABCC34-E995-447C-B868-22F1AE410E4CQ47425518-AC4ECC33-3A10-47B5-8BE4-3373A89CAE3BQ48136353-518670FD-D7C2-4A2D-BD46-35A05C8ADDFBQ52982322-DFB24906-FF09-4DB1-93DD-3BB274FBEDCE
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Theranostic applications of antibodies in oncology.
@ast
Theranostic applications of antibodies in oncology.
@en
Theranostic applications of antibodies in oncology.
@nl
type
label
Theranostic applications of antibodies in oncology.
@ast
Theranostic applications of antibodies in oncology.
@en
Theranostic applications of antibodies in oncology.
@nl
prefLabel
Theranostic applications of antibodies in oncology.
@ast
Theranostic applications of antibodies in oncology.
@en
Theranostic applications of antibodies in oncology.
@nl
P2093
P2860
P50
P1433
P1476
Theranostic applications of antibodies in oncology
@en
P2093
Carla M L van Herpen
Otto C Boerman
Sandra Heskamp
Winette T A van der Graaf
P2860
P304
P356
10.1016/J.MOLONC.2014.03.010
P577
2014-03-21T00:00:00Z